Stay updated on Navarixin and Pembrolizumab Combination Clinical Trial
Sign up to get notified when there's something new on the Navarixin and Pembrolizumab Combination Clinical Trial page.

Latest updates to the Navarixin and Pembrolizumab Combination Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision note added: v3.5.0; removed revision note: v3.4.3.SummaryDifference0.0%

- Check23 days agoChange DetectedThe page revision was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded Revision: v3.4.2; removed the earlier notices for v3.4.1 and the government funding status message.SummaryDifference0.4%

- Check59 days agoChange DetectedAdded a government funding lapse notice about NIH operations and updated the page to revision v3.4.1. The previous revision v3.4.0 was removed.SummaryDifference0.4%

- Check66 days agoChange DetectedGlossary toggle is now visible, and the page metadata has been updated to include a new 'Last Update Submitted that Met QC Criteria' entry and a revised revision to v3.4.0, along with the addition of a 'No FEAR Act Data' note; the previous QC label, FEAR Act data label, and the older v3.3.4 revision were removed.SummaryDifference0.2%

- Check80 days agoChange DetectedRevision notes show v3.3.4 added and v3.3.3 removed, indicating a minor behind-the-scenes update rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Navarixin and Pembrolizumab Combination Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Navarixin and Pembrolizumab Combination Clinical Trial page.